Authors: Gessner, U Koeberle, D Thuerlimann, B Bacchus, L Horisberger, B

Citation: U. Gessner et al., Economic analysis of terminal care for patients with malignant osteolytic bone disease and pain treated with pamidronate, SUPP CARE C, 8(2), 2000, pp. 115-122

Authors: Koeberle, D Bacchus, L Thuerlimann, B Senn, HJ

Citation: D. Koeberle et al., Pamidronate treatment in patients with malignant osteolytic bone disease and pain - A prospective randomized double-blind trial, SUPP CARE C, 7(1), 1999, pp. 21-27

Authors: Koeberle-Wuehrer, R Haid, A Sprenger-Maehr, H Koeberle, D Meusburger, E Neyer, U

Citation: R. Koeberle-wuehrer et al., Value of intraoperative blood sampling for parathyroid hormone measurementduring total parathyroidectomy and autotransplantation in patients with renal hyperparathyroidism, WIEN KLIN W, 111(6), 1999, pp. 246-250

Authors: Koeberle, D Henz, S Flury, D Mayer, R

Citation: D. Koeberle et al., Yellow-nail-syndrome, SCHW MED WO, 129(37), 1999, pp. 1342-1342

Authors: Engler, H Koeberle, D Thuerlimann, B Senn, HJ Riesen, WF

Citation: H. Engler et al., Diagnostic and prognostic value of biochemical markers in malignant bone disease: A prospective study on the effect of bisphosphonate on pain intensity and progression of malignant bone disease, CLIN CH L M, 36(11), 1998, pp. 879-885